Loading...
Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction
Glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitors, such as eptifibatide, are routinely used in the setting of acute coronary syndrome (ACS) prior to or during percutaneous coronary intervention (PCI). While numerous studies have demonstrated improved clinical outcomes with eptifibatide use, adverse effe...
Saved in:
| Published in: | Cardiol Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elmer Press
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358269/ https://ncbi.nlm.nih.gov/pubmed/28352453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/cr357w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|